agilon health inc. Quarterly Income Statements Chart
Quarterly
|
Annual
agilon health inc. Quarterly Income Statements Table
Quarterly
|
Annual
| Unit: USD | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| revenues: | |||||||||||||||||
| medical services revenue | 1,392,039,000 | 1,529,879,000 | 1,519,244,000 | 1,447,697,000 | 1,479,579,000 | 1,601,195,000 | 813,344,000 | 1,212,132,000 | 1,134,830,000 | 688,855,000 | 693,934,000 | 669,184,000 | 652,423,000 | 461,999,000 | 457,646,000 | 497,678,000 | 412,412,000 |
| other operating revenue | 2,943,000 | 2,903,000 | 3,242,000 | 3,235,000 | 3,179,000 | 3,159,000 | 2,160,000 | 3,528,000 | 1,317,000 | 919,000 | 924,000 | 950,000 | 1,022,000 | 887,000 | 967,000 | 1,278,000 | 692,000 |
| total revenues | 1,394,982,000 | 1,532,782,000 | 1,522,486,000 | 1,450,932,000 | 1,482,758,000 | 1,604,354,000 | 815,504,000 | 1,215,660,000 | 1,136,147,000 | 689,774,000 | 694,858,000 | 670,134,000 | 653,445,000 | 462,886,000 | 458,613,000 | 498,956,000 | 413,104,000 |
| yoy | -5.92% | -4.46% | 86.69% | 19.35% | 30.51% | 132.59% | 17.36% | 81.41% | 73.87% | 49.02% | 51.51% | 34.31% | 58.18% | ||||
| qoq | -8.99% | 0.68% | 4.93% | -2.15% | -7.58% | 96.73% | -32.92% | 7.00% | 64.71% | -0.73% | 3.69% | 2.55% | 41.17% | 0.93% | -8.09% | 20.78% | |
| expenses: | |||||||||||||||||
| medical services expense | 1,445,245,000 | 1,401,867,000 | 1,518,678,000 | 1,505,950,000 | 1,374,060,000 | 1,443,842,000 | 922,702,000 | 1,104,396,000 | 972,827,000 | 628,163,000 | 618,287,000 | 587,140,000 | 566,208,000 | 430,620,000 | 414,202,000 | 442,483,000 | 360,354,000 |
| other medical expenses | 2,164,000 | 80,193,000 | 42,063,000 | 9,149,000 | 76,523,000 | 85,424,000 | -11,902,000 | 80,787,000 | 86,024,000 | 51,615,000 | 50,659,000 | 49,080,000 | 44,773,000 | 22,678,000 | 29,454,000 | 33,694,000 | 23,661,000 |
| general and administrative | 56,281,000 | 65,956,000 | 59,755,000 | 63,123,000 | 69,612,000 | 76,422,000 | 63,277,000 | 74,138,000 | 66,846,000 | 75,207,000 | 51,980,000 | 51,924,000 | 39,834,000 | 341,820,000 | 34,683,000 | 43,013,000 | 37,777,000 |
| depreciation and amortization | 7,319,000 | 6,876,000 | 6,494,000 | 6,218,000 | 5,907,000 | 5,844,000 | 1,029,000 | 5,310,000 | 4,189,000 | 3,907,000 | 3,450,000 | 3,042,000 | 3,373,000 | 3,621,000 | 3,915,000 | 3,581,000 | 3,427,000 |
| total expenses | 1,511,009,000 | 1,554,892,000 | 1,630,586,000 | 1,584,440,000 | 1,526,102,000 | 1,611,532,000 | 975,106,000 | 1,264,631,000 | 1,129,886,000 | 758,892,000 | 724,376,000 | 691,186,000 | 654,188,000 | 510,759,000 | 494,214,000 | 797,319,000 | 425,219,000 |
| income from operations | -116,027,000 | -22,110,000 | -108,100,000 | -133,508,000 | -43,344,000 | -7,178,000 | -159,602,000 | -48,971,000 | 6,261,000 | -69,118,000 | -29,518,000 | -21,052,000 | -743,000 | -47,873,000 | -35,601,000 | -298,363,000 | -12,115,000 |
| yoy | 167.69% | 208.02% | -32.27% | 172.63% | -792.29% | -89.61% | 440.69% | 132.62% | -942.66% | 44.38% | -17.09% | -92.94% | -93.87% | ||||
| qoq | 424.77% | -79.55% | -19.03% | 208.02% | 503.85% | -95.50% | 225.91% | -882.16% | -109.06% | 134.16% | 40.21% | 2733.38% | -98.45% | 34.47% | -88.07% | 2362.76% | |
| operating margin % | -8.32% | -1.44% | -7.10% | -9.20% | -2.92% | -0.45% | -19.57% | -4.03% | 0.55% | -10.02% | -4.25% | -3.14% | -0.11% | -10.34% | -7.76% | -59.80% | -2.93% |
| other income: | |||||||||||||||||
| income from equity method investments | 5,412,000 | 12,672,000 | -2,694,000 | 2,047,000 | 9,955,000 | 5,684,000 | -8,018,000 | 14,659,000 | |||||||||
| other income | 7,879,000 | 9,261,000 | 7,695,000 | 16,061,000 | 4,841,000 | 5,892,000 | 6,839,000 | 5,690,000 | 9,472,000 | 14,885,000 | 574,000 | 6,997,000 | 2,269,000 | -8,534,000 | -269,000 | 2,967,000 | 1,336,000 |
| interest expense | -1,572,000 | -1,515,000 | -1,574,000 | -1,622,000 | -1,697,000 | -1,284,000 | -1,886,000 | -1,651,000 | -1,533,000 | -1,709,000 | -1,000,000 | -945,000 | -871,000 | -840,000 | -867,000 | -1,498,000 | -2,941,000 |
| income before income taxes | -104,308,000 | -1,692,000 | -104,673,000 | -117,022,000 | -30,245,000 | 3,114,000 | -162,667,000 | -30,273,000 | 14,200,000 | -55,942,000 | -29,944,000 | -20,458,000 | 655,000 | -57,247,000 | -36,737,000 | -296,894,000 | -13,720,000 |
| income tax benefit | -62,000 | -196,000 | -1,757,000 | 590,000 | -417,000 | 133,000 | -267,000 | -1,210,000 | 1,759,000 | -572,000 | -559,000 | -580,000 | 71,000 | -179,000 | -256,000 | -435,000 | -16,000 |
| income from continuing operations | -104,370,000 | -1,888,000 | -106,430,000 | -116,432,000 | -30,662,000 | 3,247,000 | -162,934,000 | -31,483,000 | 15,959,000 | -56,514,000 | -30,503,000 | -21,038,000 | 726,000 | -57,426,000 | -36,993,000 | -297,329,000 | -13,736,000 |
| discontinued operations: | |||||||||||||||||
| income before gain on sales | -425,250 | -1,183,000 | -518,000 | ||||||||||||||
| adjustments on sale of assets | 14,000,000 | ||||||||||||||||
| total discontinued operations | 14,000,000 | 640,000 | -1,183,000 | -9,281,000 | -35,000 | -236,000 | 307,000 | 429,000 | 689,000 | 1,035,000 | -1,612,000 | -1,415,000 | |||||
| net income | -104,370,000 | 12,112,000 | -105,790,000 | -117,615,000 | -30,662,000 | -6,034,000 | -230,484,000 | -31,483,000 | 15,959,000 | -56,549,000 | -30,739,000 | -20,731,000 | 1,155,000 | -56,737,000 | -35,958,000 | -298,941,000 | -15,151,000 |
| yoy | 240.39% | -300.73% | -54.10% | 273.58% | -292.13% | -89.33% | 649.81% | 51.86% | 1281.73% | -0.33% | -14.51% | -93.07% | -107.62% | ||||
| qoq | -961.71% | -111.45% | -10.05% | 283.59% | 408.15% | -97.38% | 632.09% | -297.27% | -128.22% | 83.96% | 48.28% | -1894.89% | -102.04% | 57.79% | -87.97% | 1873.08% | |
| net income margin % | -7.48% | 0.79% | -6.95% | -8.11% | -2.07% | -0.38% | -28.26% | -2.59% | 1.40% | -8.20% | -4.42% | -3.09% | 0.18% | -12.26% | -7.84% | -59.91% | -3.67% |
| noncontrolling interests’ share in (earnings) loss | -20,000 | -30,000 | 51,000 | 47,000 | 63,000 | 83,000 | 71,000 | 82,000 | 75,000 | 16,000 | 115,000 | 96,000 | |||||
| net income attributable to common shares | -104,370,000 | 12,112,000 | -105,790,000 | -117,615,000 | -30,682,000 | -6,064,000 | -230,433,000 | -31,436,000 | 16,022,000 | -56,466,000 | -30,668,000 | -20,649,000 | 1,230,000 | -56,721,000 | -35,843,000 | -298,845,000 | -15,078,000 |
| net income per common share, basic and diluted | |||||||||||||||||
| continuing operations | -250 | -260 | -290 | -70 | 10 | -400 | -80 | 40 | -140 | -70 | -50 | -140 | -90 | -790 | -40 | ||
| discontinued operations | 30 | 10 | -20 | -2.5 | -10 | ||||||||||||
| weighted-average shares outstanding | |||||||||||||||||
| basic and diluted | 413,836,000 | ||||||||||||||||
| weighted-average shares outstanding – basic and diluted | 412,936,000 | ||||||||||||||||
| gain on sales of assets | -8,763,000 | ||||||||||||||||
| weighted-average shares outstanding | |||||||||||||||||
| basic | 411,591,000 | 411,271,000 | 408,938,000 | 405,787,000 | 413,136,000 | 401,964,000 | |||||||||||
| diluted | 411,591,000 | 411,271,000 | 413,437,000 | 405,787,000 | 426,586,000 | 424,065,000 | |||||||||||
| gain on lease terminations | -5,458,000 | ||||||||||||||||
| weighted-average shares outstanding, basic and diluted | 410,966,000 | 408,917,000 | 408,154,000 | 411,065,000 | 407,339,000 | 372,931,000 | 391,229,000 | 377,445,000 | 325,659,000 | ||||||||
| stock-based compensation expense | 71,995,000 | 11,960,000 | 274,548,000 | ||||||||||||||
| noncontrolling interests’ share in earnings | 73,000 |
We provide you with 20 years income statements for agilon health inc. stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as earnings, sales and marketing expenses, research and development costs, profits, and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of agilon health inc. stock. Explore the full financial landscape of agilon health inc. stock with our expertly curated income statements.
The information provided in this report about agilon health inc. stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.